Citadel Advisors’s Avalon GloboCare ALBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8K Buy
+56,184
New +$46.6K ﹤0.01% 12572
2024
Q4
Sell
-2,539
Closed -$7.93K 14434
2024
Q3
$7.93K Buy
2,539
+1,842
+264% +$9.28K ﹤0.01% 13333
2024
Q2
$4.92K Buy
+697
New +$3.85K ﹤0.01% 13448
2021
Q3
Sell
-211
Closed -$31K 13736
2021
Q2
$31K Buy
211
+33
+19% +$5.26K ﹤0.01% 13474
2021
Q1
$29K Buy
+178
New +$33.4K ﹤0.01% 13034
2020
Q3
Sell
-78
Closed -$22K 10019
2020
Q2
$22K Sell
78
-5
-6% -$1.22K ﹤0.01% 9530
2020
Q1
$19K Buy
+83
New +$19K ﹤0.01% 9313
2019
Q2
Sell
-80
Closed -$65K 9107
2019
Q1
$65K Buy
+80
New +$53.4K ﹤0.01% 8723

Other funds holding ALBT

Citadel Advisors's ALBT Position: Q1 2026 in Review

Citadel Advisors opened a new position in Avalon GloboCare (ALBT) in Q1 2026: 56,184 shares worth $29.8K. The stake represents ﹤0.01% of the portfolio and ranks #12572 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in ALBT as recently as Q3 2024.

Citadel Advisors first reported a position in ALBT in Q1 2019 and has held it in 8 quarters since. The position peaked at $65K in Q1 2019. 20 funds tracked by Wall St. Rank hold ALBT as of Q1 2026.

  • Citadel Advisors held 56,184 shares of Avalon GloboCare worth $29.8K as of Q1 2026.
  • Avalon GloboCare was a new Citadel Advisors position in Q1 2026.
  • Avalon GloboCare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12572 holding.
  • Citadel Advisors first reported a position in Avalon GloboCare in Q1 2019 and has held it in 8 quarters since.
  • Citadel Advisors's Avalon GloboCare position peaked at $65K in Q1 2019.
  • 20 funds tracked by Wall St. Rank held Avalon GloboCare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.